Mantis Biotech has secured $7.4 million in seed funding led by Decibel VC, with participation from Y Combinator, Liquid 2, and angel investors, as it develops AI-powered synthetic data infrastructure for biomedical applications. The company is focused on addressing data scarcity in healthcare by generating high-fidelity digital twins of the human body using large language models and physics-based simulation.
Founded in New York and led by CEO Georgia Witchel, Mantis integrates diverse data sources including medical imaging, biometric sensors, and training data to build predictive models of human anatomy and behavior. The platform is designed to support drug discovery, clinical decision-making, and real-time diagnostics, particularly in edge cases such as rare diseases where data is limited.
The company is expanding its platform toward broader healthcare and research use cases, including pharmaceutical trials and preventative care.
